SCHEMBL13073091

SCHEMBL13073091

Clc1ccc(N2CCNCC2)cc1-c1nc2ccccc2[nH]1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
KDM4E B2RXH2 2/20 0.55
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
GPR55 Q9Y2T6 1/20 0.55
HTR3A P46098 2/20 0.52
ADRB1 P08588 1/20 0.50
MAPT P10636 2/20 0.47
LMNA P02545 1/20 0.47
TRPV4 Q9HBA0 1/20 0.46
HTR3E A5X5Y0 1/20 0.46
HTR3B O95264 1/20 0.46
HTR5A P47898 1/20 0.46
HTR3D Q70Z44 1/20 0.46
HTR3C Q8WXA8 1/20 0.46
SIGMAR1 Q99720 1/20 0.46
ACHE P22303 1/20 0.46
TGFB2 P61812 1/20 0.45
TP53 P04637 2/20 0.44
RXFP1 Q9HBX9 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3508040 0.95 ALDH1A1 (0.50) ALDH1A1KDM4ENPC1RAB9AGPR55
SCHEMBL13033474 0.89 KDM4E (0.56) ALDH1A1KDM4ENPC1RAB9AGPR55
SCHEMBL3509966 0.86 KDM4E (0.52) ALDH1A1KDM4ENPC1RAB9AGPR55
SCHEMBL3509601 0.85 ALDH1A1 (0.55) ALDH1A1KDM4ENPC1RAB9AHTR3A
SCHEMBL3511813 0.85 LMNA (0.58) ALDH1A1KDM4ENPC1RAB9AGPR55
SCHEMBL13033421 0.85 ADRB1 (0.47) ALDH1A1KDM4ENPC1RAB9AGPR55
SCHEMBL13033398 0.85 SSTR2 (0.54) ALDH1A1KDM4ENPC1RAB9AGPR55
SCHEMBL3511829 0.85 KDM4E (0.51) ALDH1A1KDM4ENPC1RAB9AGPR55
SCHEMBL16328077 0.85 TRPC3 (0.55) ALDH1A1KDM4ENPC1RAB9AGPR55
Hydrochloric Acid SCHEMBL3509088 0.84 LMNA (0.57) ALDH1A1KDM4ENPC1RAB9AGPR55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286114-A1 HEDGEHOG PATHWAY ANTAGONISTS AND THERAPEUTIC APPLICATIONS THEREOF SIENA BIOTECH S.P.A. (IT) 2010-11-11 US disclosed
WO-2009074300-A2 HEDGEHOG PATHWAY ANTAGONISTS AND THERAPEUTIC APPLICATIONS THEREOF SIENA BIOTECH S.P.A. (IT) 2009-06-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286114-A1 HEDGEHOG PATHWAY ANTAGONISTS AND THERAPEUTIC APPLICATIONS THEREOF SHH, GLI1, SMO ALDH1A1 2448/4885KDM4E 3170/4885NPC1 380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.